It’s not a good time for medical equipment company C.R. Bard right now. As you may have already heard, hundreds of patients who have received the company’s inferior vena cava (IVC) filters are taking legal action after the blood clot filters have caused major medical issues. Many of the Recovery IVC filter recipients allege that the filters, which are designed

Pulmonary embolism, a condition in which blood clots enter the lungs, can be extremely dangerous and often fatal. When patients aren’t able to take blood thinners to control the problem, doctors often turn to inferior vena cava (IVC) filters. Inserted into the inferior vena cava, the apparatus is designed to stop clots from causing potentially life-threatening problems. One of the

In life or death moments, patients have no choice but to trust their doctors, and ultimately, the medical equipment and devices they use. So when Bard IVC filters were implanted into hundreds of patients, many just assumed that they would be safe. Unfortunately, they were not. The Victims of the Bard IVC Filters Used to prevent blood clots from entering

Hundreds of thousands of patients receive inferior vena cava (IVC) filters every year to prevent potentially dangerous blood clots from causing catastrophic damage. Inserted into the vena cava, these filters are designed to trap blood clots and prevent any clots from traveling to the lungs. Patients who aren’t able to use blood thinners, or who don’t respond well to the

When your life is on the line, you have no choice but to trust the people who are attempting to save it, and the products that they use. If those products are dangerous, however, you can suffer serious and dangerous consequences, which is what happened to hundreds of patients who were recipients of the Bard IVC Recovery filter. The one-and-a-half-inch

In 2010, drug maker Eli Lilly introduced a new testosterone treatment known as Axiron. The drug was designed to compete with the popular testosterone medication AndroGel. Axiron was widely marketed to be safe and effective for treating low testosterone. Unfortunately, studies have now shown that use of the medication can result in dangerous side effects that may ultimately lead to

In 2010, drug maker Eli Lilly introduced a new testosterone treatment known as Axiron. The drug was designed to compete with the popular testosterone medication AndroGel. Axiron was widely marketed to be safe and effective for treating low testosterone. Unfortunately, studies have now shown that use of the medication can result in dangerous side effects that may ultimately lead to

New mind-altering drugs that are being sold as legal alternatives to marijuana and cocaine have many experts worried. Because the drugs are new and have not in many cases been thoroughly tested, they can have unpredictable results. The drugs are also not closely monitored and may combine potentially deadly ingredients. In addition, the drugs flow through the market so quickly

For more than a decade, the antipsychotic medication Risperdal has been prescribed for patients suffering from various conditions. However, use of this drug has since been linked to potentially severe adverse side effects. As a result, many patients who suffered harm after using the medication are now pursuing lawsuits against the drug’s maker. One such lawsuit recently resulted in a

Since 2011, the U.S. Food and Drug Administration (FDA) has approved the use of the drug Xarelto as a prescription blood thinner, also known as an anticoagulant. Xarelto is a relatively new drug designed to reduce the risk of blood clots in patients undergoing knee or hip replacement surgeries. The drug has also been used to treat deep vein thrombosis